Do Finnish women using hormone replacement therapy need more information about risks
- 61 Downloads
In 1998, the Women’s Health Initiative (WHI) in 2002 and the Million Women Study (MWS) in 2003 have shown a need for re-evaluation of the benefits and adverse reactions of hormone replacement therapy (HRT). Consequently the authorities in Europe and USA have issued new recommendations against the use of HRT. The aim of this study was to examine women’s perceptions of HRT since the publication of the Women’s Health Initiative study and the Million Women Study, and the kind of sources women use to obtain information about HRT.
The data was collected with questionnaire survey in the autumn 2003 among 315 women using HRT.
One third of the respondents (35%) had experienced fears concerning HRT use, and more than half (52%) reported that the debate in the media had markedly influenced them; they have experienced fears or worries, considered discontinuation or discussed with the physician. Whereas the most common source of information concerning the benefits of HRT was the physician (74%), the most common source of information concerning the risks of HRT was the media (78%).
This study shows that women using HRT should get more information about the risks from health care professionals. Physicians and pharmacists have an opportunity to alleviate fears and to help women to critically evaluate the information they get from the media. Such discussions are also important to women who have been using HRT for years.
KeywordsCounselling Finland Hormone replacement therapy HRT Medicine information
- 1.Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280:605–613PubMedCrossRefGoogle Scholar
- 2.Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Writing group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333PubMedCrossRefGoogle Scholar
- 4.USPSTF (2003) Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force. Am Fam Physician 67:358–364Google Scholar
- 5.The European Medicines Agency (2003) Public Statement on recent Publications regarding Hormone Replacement Therapy. EMEA [cited 2003 Dec 15]. Available from: http://www.emea.eu.int/pdfs/human/press/pus/3306503en.pdf
- 6.National Agency for Medicines, Social Insurance Institution. Finnish statistics on medicines, Helsinki: Edita Prima Oy, 1987–2005. ISSN 0786-2180Google Scholar
- 7.National Agency for Medicines, Social Insurance Institution (2006) Finnish statistics on medicines. Drug consumption January–June 2006. National Agency of Medicines; [cited 2006 Nov 8]. Available from: http://www.nam.fi/kulutus/kv_laakekulutus.htm
- 8.Apoteket. Läkemedelsutvecklingen - försäljingvolym januari-juni 2003. Apoteket; 2004 [cited 2004 January 8]. Available from: http://www.apoteket.se
- 11.Usher C, Teeling M, Bennet K, Feely J (2006) Effect of clinical trial publicity on HRT prescribing in Ireland. Eur J Clin Pharmacol 24:1–4 Google Scholar
- 14.Leppänen H-M, Ehkäisypillereiden käytön edut-ja haitat - tutkimus e-pillereiden käyttäjien kokemuksista [The benefits and adverse reactions of oral contraceptive users - users’ experiences]. Master’s thesis. Department of Social Pharmacy: University of Kuopio, 2001Google Scholar
- 18.Herxheimer A (1989) Regulatory Approaches. The consumer viewpoint. In: Bogaert M, v.d. Stichele R, Kaufman J-M, Levebvre R (eds). Patient package inserts as a source of drug information. Amsterdam-New York-London: Excerpta Medica, pp 73–76. ISBN 0-444-81079-XGoogle Scholar
- 23.Luoto R, Hemminki E, Kaaja R, Lindbohm M-L (2004) Hormonikorvaushoito ja kohdunpoisto [Hormone replacement therapy and hysterectomy]. In: Koponen P, Luoto R (eds). Lisääntymisterveys Suomessa [Reproductive health in Finland]. Terveys 2000-tutkimus. [The Health 2000 survey]. Helsinki: National Public Health Institute, pp 62–68. ISBN 951-740-422-0Google Scholar